{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:50:48Z","timestamp":1791089448573,"version":"4.1.0"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2012,3,29]],"date-time":"2012-03-29T00:00:00Z","timestamp":1332979200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosgenetics.org"],"crossmark-restriction":false},"short-container-title":["PLoS Genet"],"DOI":"10.1371\/journal.pgen.1002538","type":"journal-article","created":{"date-parts":[[2012,3,29]],"date-time":"2012-03-29T20:50:38Z","timestamp":1333054238000},"page":"e1002538","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgen.corrections_policy","source":"Crossref","is-referenced-by-count":38,"title":["LMW-E\/CDK2 Deregulates Acinar Morphogenesis, Induces Tumorigenesis, and Associates with the Activated b-Raf-ERK1\/2-mTOR Pathway in Breast Cancer Patients"],"prefix":"10.1371","volume":"8","author":[{"given":"MyLinh T.","family":"Duong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said","family":"Akli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caimiao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah F.","family":"Wingate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiling","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon B.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly K.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khandan","family":"Keyomarsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,3,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1128\/MCB.17.1.453","article-title":"Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E.","volume":"17","author":"DM Bortner","year":"1997","journal-title":"Mol Cell Biol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-1-4615-5371-7_14","article-title":"The role of cyclin E in cell proliferation, development and cancer.","volume":"3","author":"K Keyomarsi","year":"1997","journal-title":"Prog Cell Cycle Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1600-0560.1997.tb00796.x","article-title":"Less expression of cyclin E in cutaneous squamous cell carcinomas than in benign and premalignant keratinocytic lesions.","volume":"24","author":"T Bito","year":"1997","journal-title":"J Cutan Pathol"},{"key":"ref4","first-page":"941","article-title":"Deregulation of cyclin E in breast cancer.","volume":"11","author":"K Keyomarsi","year":"1995","journal-title":"Oncogene"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"5386","DOI":"10.1073\/pnas.92.12.5386","article-title":"Cyclins as markers of tumor proliferation: immunocytochemical studies in breast cancer.","volume":"92","author":"A Dutta","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1182\/blood.V92.3.770","article-title":"Expression of cyclin E and the cyclin-dependent kinase inhibitor p27 in malignant lymphomas-prognostic implications.","volume":"92","author":"M Erlanson","year":"1998","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/(SICI)1097-0142(19980401)82:7<1238::AID-CNCR5>3.0.CO;2-B","article-title":"Prognostic value of cyclin E and p53 expression in gastric carcinoma.","volume":"82","author":"T Sakaguchi","year":"1998","journal-title":"Cancer"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1126\/science.1388288","article-title":"Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle.","volume":"257","author":"A Koff","year":"1992","journal-title":"Science"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/0955-0674(94)90054-X","article-title":"Mammalian G1 cyclins.","volume":"6","author":"GF Draetta","year":"1994","journal-title":"Curr Opin Cell Biol"},{"key":"ref10","first-page":"1283","article-title":"Cyclin E\/Cdk2 activity is controlled by different mechanisms in the G0 and G1 phases of the cell cycle.","volume":"7","author":"WA Bresnahan","year":"1996","journal-title":"Cell Growth Differ"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1073\/pnas.90.3.1112","article-title":"Redundant cyclin overexpression and gene amplification in breast cancer cells.","volume":"90","author":"K Keyomarsi","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref12","first-page":"481","article-title":"Processing of cyclin E differs between normal and tumor breast cells.","volume":"60","author":"RM Harwell","year":"2000","journal-title":"Cancer Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"6254","DOI":"10.1128\/MCB.21.18.6254-6269.2001","article-title":"Tumor-specific proteolytic processing of cyclin E generates hyperactive lower-molecular-weight forms.","volume":"21","author":"DC Porter","year":"2001","journal-title":"Mol Cell Biol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"E101","DOI":"10.1093\/nar\/28.23.e101","article-title":"Novel splice variants of cyclin E with altered substrate specificity.","volume":"28","author":"DC Porter","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"15148","DOI":"10.1074\/jbc.M409789200","article-title":"The tumor-specific hyperactive forms of cyclin E are resistant to inhibition by p21 and p27.","volume":"280","author":"H Wingate","year":"2005","journal-title":"J Biol Chem"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1056\/NEJMoa021153","article-title":"Cyclin E and survival in patients with breast cancer.","volume":"347","author":"K Keyomarsi","year":"2002","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1535-6108(02)00125-3","article-title":"beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium.","volume":"2","author":"VM Weaver","year":"2002","journal-title":"Cancer Cell"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1242\/jcs.115.1.39","article-title":"Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition.","volume":"115","author":"T Gudjonsson","year":"2002","journal-title":"J Cell Sci"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"9064","DOI":"10.1073\/pnas.89.19.9064","article-title":"Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells.","volume":"89","author":"OW Petersen","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1242\/dev.105.2.223","article-title":"Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane.","volume":"105","author":"MH Barcellos-Hoff","year":"1989","journal-title":"Development"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ncb0901-785","article-title":"ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini.","volume":"3","author":"SK Muthuswamy","year":"2001","journal-title":"Nat Cell Biol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10549-009-0502-2","article-title":"HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment.","volume":"122","author":"B Weigelt","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ydbio.2007.03.013","article-title":"The MAPK(ERK-1,2) pathway integrates distinct and antagonistic signals from TGFalpha and FGF7 in morphogenesis of mouse mammary epithelium.","volume":"306","author":"JE Fata","year":"2007","journal-title":"Dev Biol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1158\/0008-5472.CAN-05-3071","article-title":"Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo.","volume":"66","author":"CC Park","year":"2006","journal-title":"Cancer Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.4161\/cc.8.7.8119","article-title":"Low molecular weight cyclin E is specific in breast cancer and is associated with mechanisms of tumor progression.","volume":"8","author":"H Wingate","year":"2009","journal-title":"Cell Cycle"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"11272","DOI":"10.1158\/0008-5472.CAN-07-2322","article-title":"Differential regulation of elafin in normal and tumor-derived mammary epithelial cells is mediated by CCAAT\/enhancer binding protein beta.","volume":"67","author":"T Yokota","year":"2007","journal-title":"Cancer Res"},{"key":"ref27","article-title":"Targeting low molecular weight cyclin E (LMW-E) in breast cancer.","author":"A Nanos-Webb","year":"2011","journal-title":"Breast cancer research and treatment"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1158\/0008-5472.CAN-10-4086","article-title":"Cdk2 is required for breast cancer mediated by the low-molecular-weight isoform of cyclin E.","volume":"71","author":"S Akli","year":"2011","journal-title":"Cancer Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1101\/gad.10.16.1979","article-title":"Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation.","volume":"10","author":"BE Clurman","year":"1996","journal-title":"Genes Dev"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0092-8674(02)01001-2","article-title":"The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini.","volume":"111","author":"J Debnath","year":"2002","journal-title":"Cell"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1128\/MCB.25.11.4591-4601.2005","article-title":"Bim regulation of lumen formation in cultured mammary epithelial acini is targeted by oncogenes.","volume":"25","author":"MJ Reginato","year":"2005","journal-title":"Mol Cell Biol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"7212","DOI":"10.1158\/0008-5472.CAN-07-0599","article-title":"Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.","volume":"67","author":"S Akli","year":"2007","journal-title":"Cancer Res"},{"key":"ref33","first-page":"1","article-title":"Tumor invasion and metastases\u2013role of the extracellular matrix: Rhoads Memorial Award lecture.","volume":"46","author":"LA Liotta","year":"1986","journal-title":"Cancer Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1158\/1535-7163.MCT-06-0334","article-title":"Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells.","volume":"5","author":"R Tibes","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1182\/blood-2007-10-119438","article-title":"Functional proteomic profiling of AML predicts response and survival.","volume":"113","author":"SM Kornblau","year":"2009","journal-title":"Blood"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1158\/0008-5472.CAN-08-3441","article-title":"Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics.","volume":"69","author":"BT Hennessy","year":"2009","journal-title":"Cancer Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1158\/0008-5472.CAN-09-4094","article-title":"Low molecular weight cyclin E overexpression shortens mitosis, leading to chromosome missegregation and centrosome amplification.","volume":"70","author":"R Bagheri-Yarmand","year":"2010","journal-title":"Cancer Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1158\/0008-5472.CAN-03-3672","article-title":"Tumor-specific low molecular weight forms of cyclin E induce genomic instability and resistance to p21, p27, and antiestrogens in breast cancer.","volume":"64","author":"S Akli","year":"2004","journal-title":"Cancer Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/S0002-9440(10)62541-2","article-title":"Tumor progression of skin carcinoma cells in vivo promoted by clonal selection, mutagenesis, and autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.","volume":"159","author":"MM Mueller","year":"2001","journal-title":"Am J Pathol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.4161\/cc.3.12.1279","article-title":"Regulation of cyclin E protein levels through E2F-mediated inhibition of degradation.","volume":"3","author":"D Pajalunga","year":"2004","journal-title":"Cell Cycle"},{"key":"ref41","first-page":"1173","article-title":"Regulation of cyclin E transcription by E2Fs and retinoblastoma protein.","volume":"12","author":"Y Geng","year":"1996","journal-title":"Oncogene"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1158\/1078-0432.CCR-09-1787","article-title":"Low-molecular-weight cyclin E can bypass letrozole-induced G1 arrest in human breast cancer cells and tumors.","volume":"16","author":"S Akli","year":"2010","journal-title":"Clin Cancer Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1038\/onc.2010.151","article-title":"A novel interaction between HER2\/neu and cyclin E in breast cancer.","volume":"29","author":"EA Mittendorf","year":"2010","journal-title":"Oncogene"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"7966","DOI":"10.1158\/0008-5472.CAN-08-1333","article-title":"Autophagy: a novel mechanism of synergistic cytotoxicity between doxorubicin and roscovitine in a sarcoma model.","volume":"68","author":"LA Lambert","year":"2008","journal-title":"Cancer Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1158\/0008-5472.CAN-05-0233","article-title":"Seliciclib (CYC202, R-Roscovitine) induces cell death in multiple myeloma cells by inhibition of RNA polymerase II-dependent transcription and down-regulation of Mcl-1.","volume":"65","author":"DE MacCallum","year":"2005","journal-title":"Cancer Res"},{"key":"ref46","first-page":"887","article-title":"Sensitivity of Hodgkin&apos;s lymphoma cell lines to the cell cycle inhibitor roscovitine.","volume":"28","author":"JL Foell","year":"2008","journal-title":"Anticancer Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nrm2236","article-title":"The third dimension bridges the gap between cell culture and live tissue.","volume":"8","author":"F Pampaloni","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"7095","DOI":"10.1158\/0008-5472.CAN-06-0515","article-title":"Gene expression signature in organized and growth-arrested mammary acini predicts good outcome in breast cancer.","volume":"66","author":"MV Fournier","year":"2006","journal-title":"Cancer Res"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"e2994","DOI":"10.1371\/journal.pone.0002994","article-title":"Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets.","volume":"3","author":"KJ Martin","year":"2008","journal-title":"PLoS One"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.leu.2403241","article-title":"JAK\/STAT, Raf\/MEK\/ERK, PI3K\/Akt and BCR-ABL in cell cycle progression and leukemogenesis.","volume":"18","author":"LS Steelman","year":"2004","journal-title":"Leukemia"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/sj.leu.2401720","article-title":"Differential abilities of the Raf family of protein kinases to abrogate cytokine dependency and prevent apoptosis in murine hematopoietic cells by a MEK1-dependent mechanism.","volume":"14","author":"PE Hoyle","year":"2000","journal-title":"Leukemia"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1128\/MCB.17.9.5598","article-title":"Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1.","volume":"17","author":"D Woods","year":"1997","journal-title":"Mol Cell Biol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1073\/pnas.86.4.1249","article-title":"Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types.","volume":"86","author":"V Band","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"15215","DOI":"10.1073\/pnas.93.26.15215","article-title":"Cyclin E, a redundant cyclin in breast cancer.","volume":"93","author":"J Gray-Bablin","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1535-6108(02)00212-X","article-title":"Conditional activation of Neu in the mammary epitheilium of transgenic mice results in reersible pulmonary metastasis.","volume":"2","author":"SE Moody","year":"2002","journal-title":"Cancer Cell"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1046-2023(03)00032-X","article-title":"Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures.","volume":"30","author":"J Debnath","year":"2003","journal-title":"Methods"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations.","volume":"53","author":"E Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables (with discussion).","volume":"34","author":"D Cox","year":"1972","journal-title":"J R Stat Soc Series B"}],"container-title":["PLoS Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pgen.1002538","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T11:01:09Z","timestamp":1713783669000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgen.1002538"}},"subtitle":[],"editor":[{"given":"Marshall S.","family":"Horwitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,3,29]]},"references-count":58,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,3,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgen.1002538","relation":{},"ISSN":["1553-7404"],"issn-type":[{"value":"1553-7404","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,29]]}}}